Reference Excerpt 5

Considerations for use of ketamine to treat depression in Australia and New Zealand.


By: Bayes, Adam; Dong, Vanessa; Loo, Colleen. Australian & New Zealand Journal of Psychiatry. Nov2019, Vol. 53 Issue 11, p1117-1120. 4p.

Abstract: The article discusses about the considerations for use of ketamine to treat depression in Australia and New Zealand. Topics discussed include different mechanism of action compared to standard antidepressant (AD) medications and N-methyl-Daspartate (NMDA) receptor antagonist; depression refractory to treatment with electroconvulsive therapy (ECT); and a table is also present related to State, territory and country-based regulations relevant to prescribing ketamine for depression. DOI: 10.1177/0004867419866510. (AN: 139456346)

https://search.ebscohost.com/login.aspx?direct=true&db=pbh&AN=139456346&site=ehost-live